|
Volumn 16, Issue 3, 2007, Pages 21-23
|
Evaluating cardiac risk for surgery
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTILIPEMIC AGENT;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CLOPIDOGREL;
DOBUTAMINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ANEMIA;
ANGIOCARDIOGRAPHY;
ARTICLE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
ELECTROCARDIOGRAPHY;
EXERCISE TEST;
FUNCTIONAL STATUS;
HEALTH CARE COST;
HEART DISEASE;
HEART MUSCLE REVASCULARIZATION;
HEART PROTECTION;
HEART SURGERY;
HIGH RISK PATIENT;
HUMAN;
HYPERCHOLESTEROLEMIA;
LONG TERM CARE;
MORBIDITY;
OUTCOME ASSESSMENT;
PATIENT SELECTION;
PERIOPERATIVE PERIOD;
PHARMACOLOGIC STRESS TESTING;
PHYSICAL EXAMINATION;
POSTOPERATIVE COMPLICATION;
PRACTICE GUIDELINE;
PREOPERATIVE EVALUATION;
PROGNOSIS;
RISK ASSESSMENT;
RISK REDUCTION;
STRESS ECHOCARDIOGRAPHY;
SURGICAL MORTALITY;
SURGICAL RISK;
SURGICAL TECHNIQUE;
VASCULAR SURGERY;
|
EID: 34247469333
PISSN: 15568571
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|